Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Pharmacology|October 3, 2022
Dose- and time-dependent manners of moxifloxacin induced liver injury by targeted metabolomics studyTing Hu, Yuan Sun, Zhuoling An
Frontiers in Oncology|February 7, 2022
Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting SystemHui Yang, Xiaojia Yu, Zhuoling An
Analytical Methods : Advancing Methods and Applications|October 31, 2024
Comprehensive profiling of serum glycosphingolipids to discover the diagnostic biomarkers of lung cancer and uncover the variation of glycosphingolipid networks in different lung cancer subtypesTing Hu, Feifei Han, Zhuoling An
Expert Opinion on Drug Safety|August 16, 2024
Tacrolimus related diabetic ketoacidosis and hyperglycaemic hyperosmolar nonketotic syndrome: an observational, retrospective, pharmacovigilance studyXin Wang, Hui Yang, Zhuoling An
Expert Opinion on Drug Safety|December 23, 2024
Skin cancer associated with calcineurin inhibitors treatment: analysis of FAERS databaseYuezhen Zhu, Hui Yang, Zhuoling An
Expert Opinion on Drug Safety|August 16, 2024
Catatonia related to tacrolimus: a real world pharmacovigilance study of FDA adverse event reporting system (FAERS) databaseJing Yang, Hui Yang, Zhuoling An
Expert Opinion on Drug Safety|August 23, 2023
Urinary tract infection following the use of BTK inhibitors: a real-world analysis of post-marketing surveillance dataHui Yang, Zhexin Ding, Zhuoling An
Frontiers in Chemistry|May 29, 2026
Integrative characterization of Huachansu against hepatocellular carcinoma: chemical profiling, Network pharmacology, and <i>in vivo</i> evidence of apoptosis and gut microbiota remodelingJinghui Zhang, Yang Chen, Zhuoling An, et al.
Frontiers in Oncology|April 22, 2022
Integrative Analysis of Pharmacokinetic and Metabolomic Profiles for Predicting Metabolic Phenotype and Drug Exposure Caused by Sotorasib in RatsPing Du, Lihong Liu, Ting Hu, et al.
Expert Opinion on Drug Safety|May 23, 2024
Comparison of four criteria for potentially inappropriate medications in older patients with newly diagnosed non-small cell lung cancerMan Xu, Zhuo Ma, Xin Feng, et al.
Pageof 11